Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...
Former NBA champion, Tristan Thompson, expects real-time prediction data to become a routine part of live sports coverage.
Version of Record: This is the final version of the article. In this manuscript by Lopez-Blanch and colleagues, 21 microexons are selected for a deep analysis of their impacts on behavior, development ...
In our personal and professional lives, we have numerous opportunities to communicate our ideas to others. Therefore, the importance of presentation goes beyond academic success. However, efforts to ...
Researchers at Baylor College of Medicine have developed a powerful new data analysis method named COOKIE-Pro (Covalent Occupancy Kinetic Enrichment via Proteomics) that provides a comprehensive, ...
Abstract: The research focuses on the data presentation methods of non-location-aware sensing devices. It involves manually selecting points to determine the locations of the sensing devices, ...
TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in ...
Researchers at Harbin Institute of Technology and Singapore Management University have developed LR-GCN, an advanced AI method that significantly improves how artificial intelligence handles ...
A research team has developed a novel method for estimating the predictability of complex dynamical systems. Their work, "Time-lagged recurrence: A data-driven method to estimate the predictability of ...
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...
Windtree Therapeutics, Inc. announced that data from the SEISMiC Extension Phase 2b study on istaroxime will be presented at the European Society of Cardiology Heart Failure 2025 Conference in ...
SPRING Trial Data Presented at Digestive Disease Week® 2025 Shows that Nebokitug at 15 and 48 Weeks of Treatment Is Well-Tolerated and Associated with Significant Improvements in Multiple Fibrotic and ...